Covered recipient · General Payments record
MELANIE A SWEENEY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$3,937.48
- Reported across 48 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,258.39 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $369.78 | 3 |
| CeQur Corporation | $194.07 | 1 |
| GlaxoSmithKline, LLC. | $134.31 | 2 |
| ABBVIE INC. | $124.98 | 1 |
| SANOFI-AVENTIS U.S. LLC | $123.92 | 1 |
| Novo Nordisk AS | $121.83 | 1 |
| Lilly USA, LLC | $107.15 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $82.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $124.98 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108278054 | CMS |
| AIMMUNE THERAPEUTICS, INC. | $82.35 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146969033 | CMS |
| AstraZeneca Pharmaceuticals LP | $125.00 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104402667 | CMS |
| AstraZeneca Pharmaceuticals LP | $122.95 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104380247 | CMS |
| AstraZeneca Pharmaceuticals LP | $121.83 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105798172 | CMS |
| CeQur Corporation | $194.07 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1099650461 | CMS |
| GlaxoSmithKline, LLC. | $12.48 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116625728 | CMS |
| GlaxoSmithKline, LLC. | $121.83 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116725926 | CMS |
| Lilly USA, LLC | $107.15 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135843280 | CMS |
| Novo Nordisk Inc | $121.83 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100438807 | CMS |
| SANOFI-AVENTIS U.S. LLC | $123.92 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139745960 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.